Clinical Trial Update: A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating inhaled single doses of different GW642444M formulations in asthmatic patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GW642444M (GW642444M)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED